Cryoablation for T1a RCC Linked With Good Long-Term Outcomes
No residual malignancy was found in 98% of patients treated with percutaneous cryoablation.
No residual malignancy was found in 98% of patients treated with percutaneous cryoablation.
Cardiovascular disease is a leading cause of noncancer death in men with prostate cancer.
Study findings support AUA guidelines to consider antibiotic prophylaxis at the time of catheter removal.
The optimal duration of antibiotic prophylaxis is still unknown.
PSA response is an important early indicator of progression-free survival in mHSPC.
Study findings support counseling patients about the possibility of conservative kidney stone management.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Kidney function remained stable throughout the 25 week treatment period.
Most states covering outpatient hemodialysis for undocumented immigrants use emergency Medicaid.
Slow metabolizers of caffeine genetically comprise half of the Italian population.